Can the loop reward improve the therapeutic effect of African AIDS patients?

On November 1st, the block chain Medical Ecosystem Immunife.life and Masindemuliro University of Technology announced that they have obtained the approval of the Ethics Committee and the National Committee to launch this study.

They will jointly conduct a five-year AIDS study in Kakameg County, Kenya, and then promoted to other parts of the country.

This study aims to investigate the effectiveness of HIV treatment results in the low environment of Kenya in the low environment of Kenya.

MMUST will use the block chain technology of Immunify.life to collect and analyze patient data to help improve HIV treatment. It will evaluate if there is a better treatment result if the health positive act of non-governmental organizations and government agencies is given.

Immunify.life CEO Guy Newing said: “We are testing the plans to provide partin incentives to encourage patients to receive treatment to the clinic.”

Patients and doctors will receive IMMunify.life’s ERC-20 IMM local login reward. He added that these can be used to “Complete the prescribed tuberculosis antibiotics”, and incentive “AIDS patients regularly return to the clinic for examination and treatment.”

Newing said that the positive behavior of medical staff will also be rewarded, such as “correctly fill in the consultation record, arrange a certain number of tuberculosis detection, or complete medical education”.

Each patient who uses this platform will receive an NFT health ID for capturing key medical data, such as vaccination records. These data are then transferred to a digital registry to achieve remote medical supervision and real-time data access of medical professionals.

The sample volume of this study was 600 patients. Half will get the same amount of money, and the other half will not get the loop reward. These patients will receive six months of monitoring and will receive active treatment and monitoring monthly monthly.

This study will track the effects of using paperless medical tracking systems in areas with lower socio-economic levels.

In addition to the bonus rewards provided by the sponsor, patients will also obtain economic benefits from anonymous medical data. Immunify.life is currently conducting private financing for strategic and institutional investors, and then plans to conduct first DEX issuance (IDO) in early 2022.

Newing said: “Patient will have the right to control its own data and share the economic return. The funds of the system come from the cost of subsidizing and providing health care.”

In addition to HIV treatment in Kenya, Immunife.life also applies its block chain technology to other two treatment areas, new gangnamonia and opioid drug addiction.

According to UNAIDS reported 2020 report, Kenya has approximately 1.5 million AIDS carriers. Although 70% of patients have been treated, there is currently difficulties in tracking, access, programming, and data collection.

Many HIV carriers cannot continue to be treated. According to the data of Immunify.life, in some areas, these “loss” patients may be as high as 40%. These include pregnant women, they may infect the virus to their children during childbirth.